Copertina

Group sequential designs for clinical trials when the maximum sample size is uncertain

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Amin Yarahmadi, Lori E. Dodd, Thomas Jaki, Peter Horby, Nigel Stallard
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Statistics in Medicine
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Adding experimental treatment arms to multi‐arm multi‐stage platform trials in progress
di: Thomas Burnett, et al.
Pubblicazione: (2024)

A multi‐arm multi‐stage platform design that allows preplanned addition of arms while still controlling the family‐wise error
di: Peter Greenstreet, et al.
Pubblicazione: (2024)

A class of computational methods to reduce selection bias when designing Phase 3 clinical trials
di: Tianyu Zhan
Pubblicazione: (2024)

A sequential, multiple assignment, randomized trial design with a tailoring function
di: Holly Hartman, et al.
Pubblicazione: (2024)

A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart
di: Stephen Schüürhuis, et al.
Pubblicazione: (2024)

Assurance methods for designing a clinical trial with a delayed treatment effect
di: James A. Salsbury, et al.
Pubblicazione: (2024)

Validation of predicted individual treatment effects in out of sample respondents
di: Alena Kuhlemeier, et al.
Pubblicazione: (2024)

Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design
di: Yunfei Wang
Pubblicazione: (2024)

Doubly adaptive biased coin design to improve Bayesian clinical trials with time‐to‐event endpoints
di: Wenhao Cao, et al.
Pubblicazione: (2024)

Are the tests overpowered or underpowered? A unified solution to correctly specify type I errors in design of clinical trials for two sample proportions
di: Peiran Liu, et al.
Pubblicazione: (2024)

Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs
di: Luana Boumendil, et al.
Pubblicazione: (2024)

Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials
di: Jialu Fang, et al.
Pubblicazione: (2024)

Assessing efficacy in non‐inferiority trials with non‐adherence to interventions: Are intention‐to‐treat and per‐protocol analyses fit for purpose?
di: Matthew Dodd, et al.
Pubblicazione: (2024)

Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance
di: David S. Robertson, et al.
Pubblicazione: (2025)

Determining sample size in a personalized randomized controlled (PRACTical) trial
di: Rebecca M. Turner, et al.
Pubblicazione: (2024)

Correction to “Using principal stratification in analysis of clinical trials”
di: Ilya Lipkovich, et al.
Pubblicazione: (2024)

Use of win time for ordered composite endpoints in clinical trials
di: James F. Troendle, et al.
Pubblicazione: (2024)

Confidence distributions for treatment effects in clinical trials: Posteriors without priors
di: Ian C. Marschner
Pubblicazione: (2024)

Correction to “Propensity score weighting for covariate adjustment in randomized clinical trials”
di: Shuxi Zeng, et al.
Pubblicazione: (2024)

A hybrid approach to sample size re‐estimation in cluster randomized trials with continuous outcomes
di: Samuel K Sarkodie, et al.
Pubblicazione: (2024)

Design and sample size determination for multiple‐dose randomized phase II trials for dose optimization
di: Peng Yang, et al.
Pubblicazione: (2024)

Sample size calculation for comparing two screening tests when the gold standard is missing at random
di: Yougui Wu
Pubblicazione: (2024)

A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials
di: Yu Du, et al.
Pubblicazione: (2024)

Clinical Trial Simulation: Planning With the OCTAVE Framework, Implementation and Validation Principles
di: Kim May Lee, et al.
Pubblicazione: (2026)

Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs
di: Jonathan C. Moyer, et al.
Pubblicazione: (2024)

Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time‐to‐event endpoints
di: Matthias Kormaksson, et al.
Pubblicazione: (2024)

Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial
di: Johannes Krisam, et al.
Pubblicazione: (2024)

Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table
di: Edward L. Korn, et al.
Pubblicazione: (2024)

A Unified Framework for Modeling Feedback and Endogeneity in Longitudinal Binary Outcomes Using Bayesian Methods
di: Lori P. Selby, et al.
Pubblicazione: (2025)

Utilizing local likelihood in regression discontinuity design: Investigating the impact of antiretroviral therapy eligibility on retention in clinical HIV care in South Africa
di: Jaehyun Seo, et al.
Pubblicazione: (2024)

Improved mortality analysis in early‐phase dose‐ranging clinical trials for emergency medical diseases using Bayesian time‐to‐event models with active comparators
di: Xiaosong Shi, et al.
Pubblicazione: (2024)

Covariate‐Adjusted Group Sequential Comparisons of Survival Probabilities
di: Peter Zhang, et al.
Pubblicazione: (2025)

Comparing two hazard curves when there is a treatment time‐lag effect
di: Xiaoxi Zhang, et al.
Pubblicazione: (2024)

Beyond the two‐trials rule
di: Leonhard Held
Pubblicazione: (2024)

Approximate maximum likelihood estimation in cure models using aggregated data, with application to HPV vaccine completion
di: John D. Rice, et al.
Pubblicazione: (2024)

Effective sample size: A measure of individual uncertainty in predictions
di: Doranne Thomassen, et al.
Pubblicazione: (2024)

Bayesian Additive Regression Trees for Group Testing Data
di: Madeleine E. St. Ville, et al.
Pubblicazione: (2025)

Spatial Individual‐Level Models for Transmission Dynamics of Seasonal Infectious Diseases
di: Amin Abed, et al.
Pubblicazione: (2026)

Robust analysis of stepped wedge trials using composite likelihood models
di: Emily C. Voldal, et al.
Pubblicazione: (2024)

Modeling intra‐individual inter‐trial EEG response variability in autism
di: Mingfei Dong, et al.
Pubblicazione: (2024)